Compounds > n-cyano-n'-(1,1-dimethylpropyl)-n''-(3-pyridinyl)guanidine
Page last updated: 2024-08-23

n-cyano-n'-(1,1-dimethylpropyl)-n''-(3-pyridinyl)guanidine and Goldblatt Syndrome

n-cyano-n'-(1,1-dimethylpropyl)-n''-(3-pyridinyl)guanidine has been researched along with Goldblatt Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fu, AL; He, HM; Long, CL; Wang, H; Zhang, LZ1

Other Studies

1 other study(ies) available for n-cyano-n'-(1,1-dimethylpropyl)-n''-(3-pyridinyl)guanidine and Goldblatt Syndrome

ArticleYear
Alteration of binding sites for [3H]P1075 and [3H]glibenclamide in renovascular hypertensive rat aorta.
    Acta pharmacologica Sinica, 2005, Volume: 26, Issue:1

    Topics: Animals; Antihypertensive Agents; Aorta; Binding Sites; Glyburide; Guanidines; Hypertension, Renovascular; In Vitro Techniques; Kinetics; Male; Pinacidil; Potassium Channels; Pyridines; Rats; Rats, Wistar; Vasodilator Agents

2005